SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CROCE, Carlo Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.778
AS - Asia 10.847
EU - Europa 5.368
SA - Sud America 1.757
Continente sconosciuto - Info sul continente non disponibili 334
AF - Africa 234
OC - Oceania 16
Totale 42.334
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.316
SG - Singapore 4.057
CN - Cina 2.640
BR - Brasile 1.361
VN - Vietnam 1.198
UA - Ucraina 1.038
HK - Hong Kong 989
IT - Italia 892
DE - Germania 821
TR - Turchia 664
GB - Regno Unito 575
PL - Polonia 415
FI - Finlandia 360
FR - Francia 341
BD - Bangladesh 306
SE - Svezia 280
RU - Federazione Russa 269
IN - India 221
CA - Canada 195
JP - Giappone 195
MX - Messico 164
AR - Argentina 147
ID - Indonesia 142
NL - Olanda 88
ZA - Sudafrica 70
IQ - Iraq 68
ES - Italia 67
PK - Pakistan 65
EC - Ecuador 57
CO - Colombia 55
AT - Austria 46
VE - Venezuela 42
UZ - Uzbekistan 41
SA - Arabia Saudita 39
BE - Belgio 35
MA - Marocco 31
PH - Filippine 31
CL - Cile 28
TN - Tunisia 28
JM - Giamaica 25
MY - Malesia 24
EG - Egitto 22
IR - Iran 22
LT - Lituania 20
CH - Svizzera 19
CR - Costa Rica 19
KE - Kenya 19
KR - Corea 19
BO - Bolivia 17
PY - Paraguay 17
AU - Australia 16
UY - Uruguay 16
AE - Emirati Arabi Uniti 15
CZ - Repubblica Ceca 15
ET - Etiopia 14
DZ - Algeria 13
HN - Honduras 13
NP - Nepal 13
PE - Perù 13
IL - Israele 10
JO - Giordania 10
RO - Romania 10
AL - Albania 9
GR - Grecia 9
TH - Thailandia 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
PT - Portogallo 8
SV - El Salvador 8
IE - Irlanda 7
KZ - Kazakistan 7
LY - Libia 7
PS - Palestinian Territory 7
RS - Serbia 7
HU - Ungheria 6
OM - Oman 6
BG - Bulgaria 5
GT - Guatemala 5
LB - Libano 5
NG - Nigeria 5
PA - Panama 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
EU - Europa 4
MD - Moldavia 4
MN - Mongolia 4
QA - Qatar 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AO - Angola 3
BF - Burkina Faso 3
BH - Bahrain 3
BM - Bermuda 3
BY - Bielorussia 3
DK - Danimarca 3
KW - Kuwait 3
LC - Santa Lucia 3
LV - Lettonia 3
MU - Mauritius 3
NI - Nicaragua 3
Totale 41.956
Salva come PNG Salva come JPEG
Città #
Fairfield 2.682
Singapore 2.558
Ashburn 2.491
Woodbridge 2.480
Houston 1.584
San Jose 1.280
Jacksonville 1.146
Seattle 1.061
Chandler 993
Hong Kong 977
Ann Arbor 893
Wilmington 881
Cambridge 859
Santa Clara 772
Beijing 744
Izmir 415
Warsaw 402
Ho Chi Minh City 361
Nanjing 335
Los Angeles 329
Dallas 256
Hanoi 255
Princeton 251
San Diego 234
Council Bluffs 219
New York 216
Lauterbourg 204
Boardman 199
Tokyo 183
Ferrara 155
Milan 152
Munich 142
Addison 121
São Paulo 105
Helsinki 101
Mexico City 97
Dong Ket 96
Shanghai 96
Nanchang 94
Shenyang 92
Jakarta 89
Orem 89
Hefei 82
Dearborn 76
Atlanta 75
Chicago 72
Hebei 68
Tianjin 68
London 65
Rome 61
Buffalo 60
Mountain View 59
Toronto 58
Jinan 57
Bremen 55
Da Nang 55
Brooklyn 54
Jiaxing 53
Montreal 50
The Dalles 50
Denver 45
Haiphong 45
San Francisco 45
Changsha 44
Kunming 43
Rio de Janeiro 43
Turku 42
Falls Church 41
Hangzhou 41
Johannesburg 41
Chennai 40
Moscow 40
Redwood City 40
Columbus 39
Frankfurt am Main 36
Norwalk 36
San Mateo 36
Tashkent 36
Manchester 35
Phoenix 35
Falkenstein 34
Guangzhou 34
Zhengzhou 33
Nuremberg 32
Stockholm 32
Brussels 31
Mumbai 31
Boston 30
Amsterdam 28
Hải Dương 28
Poplar 28
Tappahannock 28
Brasília 27
Orange 27
Philadelphia 27
Washington 27
Belo Horizonte 26
Des Moines 26
Ningbo 26
Bologna 24
Totale 29.189
Salva come PNG Salva come JPEG
Nome #
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 364
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 305
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 305
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 302
Loss of miR-204 expression is a key event in melanoma 289
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 282
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 277
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 276
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 274
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 269
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 266
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 265
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 262
A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer 259
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 259
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 258
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 257
MicroRNA expression profiling in human Barrett's carcinogenesis. 256
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 253
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 252
MicroRNA involvement in hepatocellular carcinoma 242
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 241
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 239
A microRNA DNA methylation signature for human cancer metastasis 237
MicroRNA e cancro 237
Identification of microRNA activity by Targets' Reverse EXpression. 236
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 236
Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo 231
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 231
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 228
Reprogramming of miRNA networks in cancer and leukemia 227
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 225
A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention 224
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 224
A microRNA signature of hypoxia 223
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation 223
Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status 221
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 219
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 218
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 218
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 217
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 217
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma 217
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer 217
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 216
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 214
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 213
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 212
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer 211
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 210
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 208
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 207
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 205
MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC 205
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 205
Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis 203
Espressione dei MicroRNA nei carcinomi mammari 203
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 202
Aberrant FHIT transcripts in Merkel cell carcinoma 201
Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features 201
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation 201
Strong inverse correlation between MicroRNA-125b and human papillomavirus DNA in productive infection 200
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model 199
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 198
Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas 197
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 197
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 196
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 196
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 195
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 195
MicroRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 194
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 194
ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias 193
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 191
Knockout mice reveal a tumor suppressor function for Testin 190
Tumor suppressor functions of ARLTS1 in lung cancers 190
Mutated beta-catenin evades a microRNA-dependent regulatory loop 190
Extensive modulation of a set of microRNAs in primary glioblastoma 189
Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization 189
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 189
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 186
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 186
MicroRNA-133 controls cardiac hypertrophy 185
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function 185
The role of microRNA genes in papillary thyroid carcinoma 185
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 184
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway 184
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer 184
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 183
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 181
MicroRNA deregulation in human thyroid papillary carcinomas 181
Alternative splicing, genomic structure, and fine chromosome localization of REV3L 180
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers 179
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 177
Modulation of mismatch repair and genomic stability by miR-155 176
MicroRNA profiles discriminate among colon cancer metastasis 175
MicroRNA genes are frequently located near mouse cancer susceptibility loci 174
microRNA involvement in hepatocellular carcinoma 174
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer 174
Oncogenic role of miR-483-3p at the IGF2/483 locus 174
Totale 21.784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 186.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.549
Totale 188.244
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.607 0 318 263 67 95 108 151 135 80 201 287 902
2022/20232.423 249 98 61 306 380 391 103 259 323 19 131 103
2023/20241.074 126 169 60 38 79 182 32 69 23 18 30 248
2024/20254.586 144 94 387 137 585 360 160 283 851 471 649 465
2025/202614.174 1.194 650 1.219 1.860 1.889 828 1.714 812 1.523 1.459 726 300
2026/2027757 355 402 0 0 0 0 0 0 0 0 0 0
Totale 42.334